JP2002523518A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523518A5
JP2002523518A5 JP2000567569A JP2000567569A JP2002523518A5 JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5 JP 2000567569 A JP2000567569 A JP 2000567569A JP 2000567569 A JP2000567569 A JP 2000567569A JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid
hydrophobic amino
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523518A (ja
JP4528443B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/019378 external-priority patent/WO2000012553A1/en
Publication of JP2002523518A publication Critical patent/JP2002523518A/ja
Publication of JP2002523518A5 publication Critical patent/JP2002523518A5/ja
Application granted granted Critical
Publication of JP4528443B2 publication Critical patent/JP4528443B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567569A 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用 Expired - Fee Related JP4528443B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
US60/098,359 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010034833A Division JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2002523518A JP2002523518A (ja) 2002-07-30
JP2002523518A5 true JP2002523518A5 (enExample) 2006-08-10
JP4528443B2 JP4528443B2 (ja) 2010-08-18

Family

ID=22268937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000567569A Expired - Fee Related JP4528443B2 (ja) 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Country Status (13)

Country Link
EP (1) EP1105420A1 (enExample)
JP (2) JP4528443B2 (enExample)
KR (1) KR20010079695A (enExample)
CN (1) CN1324367A (enExample)
AU (1) AU751034B2 (enExample)
BR (1) BR9913490A (enExample)
CA (1) CA2341810A1 (enExample)
CZ (1) CZ2001655A3 (enExample)
HU (1) HUP0103265A3 (enExample)
IL (1) IL141586A0 (enExample)
PL (1) PL204359B1 (enExample)
WO (1) WO2000012553A1 (enExample)
ZA (1) ZA200102489B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
AU751034B2 (en) * 1998-08-28 2002-08-08 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
JP5437790B2 (ja) 2006-04-28 2014-03-12 チルドレンズ ホスピタル メディカル センター 膜貫通薬物送達システムに適用するためのプロサポシン由来の融合タンパク質又はポリペプチドを含む組成物
BRPI0717475A2 (pt) * 2006-10-20 2014-03-11 Childrens Hosp Medical Center Vesículas unilamelares de fosfolipídio elipsoidal de formação espontânea
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
BR112017022021B1 (pt) 2015-04-23 2021-07-06 The Procter & Gamble Company Composição para tratamento dos cabelos
EP3423031B1 (en) 2016-03-03 2021-09-08 The Procter & Gamble Company Aerosol antidandruff composition
CN109789076A (zh) 2016-10-21 2019-05-21 宝洁公司 具有低粘度和粘度降低剂的稳定致密洗发剂产品
CN109843258A (zh) 2016-10-21 2019-06-04 宝洁公司 表示毛发调理有益效果的浓缩型洗发剂泡沫剂型
US11141361B2 (en) 2016-10-21 2021-10-12 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair volume benefits
US10888505B2 (en) 2016-10-21 2021-01-12 The Procter And Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
EP3528895A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US20180110688A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated Shampoo Dosage of Foam for Providing Hair Care Benefits
US10842720B2 (en) 2016-10-21 2020-11-24 The Procter And Gamble Company Dosage of foam comprising an anionic/zwitterionic surfactant mixture
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
EP4427727A3 (en) 2017-10-10 2024-12-18 The Procter & Gamble Company Compact shampoo composition containing sulfate-free surfactants
JP6952906B2 (ja) 2017-10-10 2021-10-27 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 泡形態のパーソナルケア組成物で毛髪又は皮膚を処理する方法
EP3694481B1 (en) 2017-10-10 2024-06-05 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
WO2019074992A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company CLEANING ORGANIC HYGIENE COMPOSITION WITHOUT SULFATES WITH LOW INORGANIC SALT CONTENT
EP3727323A1 (en) 2017-12-20 2020-10-28 The Procter & Gamble Company Clear shampoo composition containing silicone polymers
MX2020014144A (es) 2018-06-29 2021-03-25 Procter & Gamble Composicion anticaspa en aerosol con bajo contenido de surfactante.
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
JP7410298B2 (ja) 2019-12-06 2024-01-09 ザ プロクター アンド ギャンブル カンパニー 頭皮活性物質の付着を強化する硫酸塩を含まない組成物
JP7481470B2 (ja) 2020-02-27 2024-05-10 ザ プロクター アンド ギャンブル カンパニー 有効性及び美観が強化された硫黄含有フケ防止組成物
JP7678101B2 (ja) 2020-11-23 2025-05-15 ザ プロクター アンド ギャンブル カンパニー 硫酸化界面活性剤を含まないパーソナルケア組成物
JP7768985B2 (ja) 2020-12-04 2025-11-12 ザ プロクター アンド ギャンブル カンパニー 悪臭低減物質を含むヘアケア組成物
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
WO2023108097A1 (en) 2021-12-09 2023-06-15 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
AU751034B2 (en) * 1998-08-28 2002-08-08 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP2002523518A5 (enExample)
US5482706A (en) Transmucosal therapeutic composition
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
US5854211A (en) Compounds with growth hormone releasing properties
US5470828A (en) Peptide analogs of insulin-like growth factor II
ATE206716T1 (de) Cyclische wirkstoff-vorläufer verbindungen von peptiden und peptid-nukleicsäuren mit verbesserter metabolischer stabilität und zellmembran permeabilität
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
EP1077070A3 (en) Oral drug delivery compositions
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JP2002524393A5 (enExample)
ATE172742T1 (de) Peptide mit wachstumshormonfreisetzender aktivität
Fujino et al. Syntheses and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH)
JP2004531242A5 (enExample)
KR950032275A (ko) 시클로펩티드 유도체 및 이의 제조방법
RU2000109265A (ru) Лечение ожирения
CA2311648A1 (en) Ifnar2/ifn complex
US4684624A (en) Method of treating cerebral ischemia
HUT77979A (hu) Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
JP2000502089A (ja) 成長ホルモンの放出を促進できるd―2―アルキルトリプトファンを含有するオリゴペプチド化合物
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
Friedman et al. Characterization of the intestinal transport parameters for small peptide drugs
CA2465667A1 (en) New peptides - analogs of human growth hormone-releasing hormone
IE58407B1 (en) Peptides
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
CA2139571A1 (en) Interferon receptor binding peptides